{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:20:08Z","timestamp":1783606808431,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/npp.2011.17","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T15:00:02Z","timestamp":1300287602000},"page":"1340-1348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study"],"prefix":"10.1038","volume":"36","author":[{"given":"Toby T","family":"Winton-Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Bhattacharrya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J","family":"Borgwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Martin-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Ffytche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio W","family":"Zuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerrin","family":"Atakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip K","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,16]]},"reference":[{"key":"BFnpp201117_CR1","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/BF02085029","volume":"37","author":"S Agurell","year":"1981","unstructured":"Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L (1981). Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia 37: 1090\u20131092.","journal-title":"Experientia"},{"key":"BFnpp201117_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neubiorev.2007.07.012","volume":"32","author":"P Allen","year":"2008","unstructured":"Allen P, Laroi F, McGuire PK, Aleman A (2008). The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations. Neurosci Biobehav Rev 32: 175\u2013191.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp201117_CR3","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.2174\/138161209788957465","volume":"15","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Crippa JA, Martin-Santos R, Winton-Brown T, Fusar-Poli P (2009a). Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des 15: 2603\u20132614.","journal-title":"Curr Pharm Des"},{"key":"BFnpp201117_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","volume":"66","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O\u2019Carroll C et al (2009b). Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 66: 442\u2013451.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201117_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","volume":"64","author":"SJ Borgwardt","year":"2008","unstructured":"Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, Seal ML et al (2008). Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry 64: 966\u2013973.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201117_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0091-3057(90)90371-N","volume":"35","author":"GB Chesher","year":"1990","unstructured":"Chesher GB, Bird KD, Jackson DM, Perrignon A, Starmer GA (1990). The effects of orally administered delta 9-tetrahydrocannabinol in man on mood and performance measures: a dose-response study. Pharmacol Biochem Behav 35: 861\u2013864.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201117_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.npp.1300340","volume":"29","author":"JA Crippa","year":"2004","unstructured":"Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, Ferrari L et al (2004). Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology 29: 417\u2013426.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201117_CR8","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"DC D\u2019Souza","year":"2004","unstructured":"D\u2019Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT et al (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558\u20131572.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201117_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cortex.2008.04.005","volume":"44","author":"DH ffytche","year":"2008","unstructured":"ffytche DH (2008). The hodology of hallucinations. Cortex 44: 1067\u20131083.","journal-title":"Cortex"},{"key":"BFnpp201117_CR10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/3738","volume":"1","author":"DH ffytche","year":"1998","unstructured":"ffytche DH, Howard RJ, Brammer MJ, David A, Woodruff P, Williams S (1998). The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci 1: 738\u2013742.","journal-title":"Nat Neurosci"},{"key":"BFnpp201117_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1017\/S0033291700054283","volume":"3","author":"MF Folstein","year":"1973","unstructured":"Folstein MF, Luria R (1973). Reliability, validity, and clinical application of the Visual Analogue Mood Scale. Psychol Med 3: 479\u2013486.","journal-title":"Psychol Med"},{"key":"BFnpp201117_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","volume":"66","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R et al (2009). Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural acti. Arch Gen Psychiatry 66: 95\u2013105.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201117_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/09595230310001613976","volume":"22","author":"B Green","year":"2003","unstructured":"Green B, Kavanagh D, Young R (2003). Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 22: 453\u2013460.","journal-title":"Drug Alcohol Rev"},{"key":"BFnpp201117_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cogbrainres.2005.02.016","volume":"23","author":"SA Gruber","year":"2005","unstructured":"Gruber SA, Yurgelun-Todd DA (2005). Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res 23: 107\u2013118.","journal-title":"Brain Res Cogn Brain Res"},{"key":"BFnpp201117_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1360-0443.2000.9544851.x","volume":"95","author":"W Hall","year":"2000","unstructured":"Hall W, Babor TF (2000). Cannabis use and public health: assessing the burden. Addiction 95: 485\u2013490.","journal-title":"Addiction"},{"key":"BFnpp201117_CR16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","volume":"352","author":"W Hall","year":"1998","unstructured":"Hall W, Solowij N (1998). Adverse effects of cannabis. Lancet 352: 1611\u20131616.","journal-title":"Lancet"},{"key":"BFnpp201117_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cortex.2009.01.002","volume":"45","author":"Y Harpaz","year":"2009","unstructured":"Harpaz Y, Levkovitz Y, Lavidor M (2009). Lexical ambiguity resolution in Wernicke's area and its right homologue. Cortex 45: 1097\u20131103.","journal-title":"Cortex"},{"key":"BFnpp201117_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/BF00401256","volume":"11","author":"H Isbell","year":"1967","unstructured":"Isbell H, Gorodetzsky CW, Jasinski D, Claussen U, von Spulak F, Korte F (1967). Effects of (\u2014)delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia 11: 184\u2013188.","journal-title":"Psychopharmacologia"},{"key":"BFnpp201117_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.euroneuro.2006.10.003","volume":"17","author":"G Jager","year":"2007","unstructured":"Jager G, Van Hell HH, De Win MM, Kahn RS, Van Den Brink W, Van Ree JM et al (2007). Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol 17: 289\u2013297.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp201117_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.tics.2005.09.009","volume":"9","author":"M Jung-Beeman","year":"2005","unstructured":"Jung-Beeman M (2005). Bilateral brain processes for comprehending natural language. Trends in Cognitive Sciences 9: 512\u2013518.","journal-title":"Trends in Cognitive Sciences"},{"key":"BFnpp201117_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261\u2013276.","journal-title":"Schizophr Bull"},{"key":"BFnpp201117_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.schres.2006.07.023","volume":"88","author":"D Koethe","year":"2006","unstructured":"Koethe D, Gerth CW, Neatby MA, Haensel A, Thies M, Schneider U et al (2006). Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Schizophr Res 88: 142\u2013150.","journal-title":"Schizophr Res"},{"key":"BFnpp201117_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130050884","volume":"142","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Schneider U, Thies M, M\u00fcnte TF, Emrich HM (1999). Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology (Berl) 142: 230\u2013235.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201117_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1600-0447.1999.tb10916.x","volume":"100","author":"RJ Mathew","year":"1999","unstructured":"Mathew RJ, Wilson WH, Chiu NY, Turkington TG, Degrado TR, Coleman RE (1999). Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatr Scand 100: 67\u201375.","journal-title":"Acta Psychiatr Scand"},{"key":"BFnpp201117_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","volume":"9","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G et al (1992). The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 9: 199\u2013213.","journal-title":"J Subst Abuse Treat"},{"key":"BFnpp201117_CR26","first-page":"175","volume":"25","author":"R Mechoulam","year":"1967","unstructured":"Mechoulam R, Gaoni Y (1967). Recent advances in the chemistry of hashish. Fortschr Chem Org Naturst 25: 175\u2013213.","journal-title":"Fortschr Chem Org Naturst"},{"key":"BFnpp201117_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nrn2253","volume":"8","author":"RM Murray","year":"2007","unstructured":"Murray RM, Morrison PD, Henquet C, Di Forti M (2007). Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 8: 885\u2013895.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp201117_CR28","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1097\/00001756-200011270-00047","volume":"11","author":"DS O\u2019Leary","year":"2000","unstructured":"O\u2019Leary DS, Block RI, Flaum M, Schultz SK, Boles Ponto LL, Watkins GL et al (2000). Acute marijuana effects on rCBF and cognition: a PET study. Neuroreport 11: 3835\u20133841.","journal-title":"Neuroreport"},{"key":"BFnpp201117_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0893-133X(01)00425-0","volume":"26","author":"DS O\u2019Leary","year":"2002","unstructured":"O\u2019Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC et al (2002). Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 26: 802\u2013816.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201117_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/hup.832","volume":"22","author":"DS O\u2019Leary","year":"2007","unstructured":"O\u2019Leary DS, Block RI, Koeppel JA, Schultz SK, Magnotta VA, Ponto LB et al (2007). Effects of smoking marijuana on focal attention and brain blood flow. Hum Psychopharmacol 22: 135\u2013148.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp201117_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pscychresns.2007.09.004","volume":"156","author":"V Oertel","year":"2007","unstructured":"Oertel V, Rotarska-Jagiela A, van de Ven VG, Haenschel C, Maurer K, Linden DE (2007). Visual hallucinations in schizophrenia investigated with functional magnetic resonance imaging. Psychiatry Res 156: 269\u2013273.","journal-title":"Psychiatry Res"},{"key":"BFnpp201117_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 153: 199\u2013215.","journal-title":"Br J Pharmacol"},{"issue":"Part 3","key":"BFnpp201117_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/brain\/119.3.919","volume":"119","author":"CJ Price","year":"1996","unstructured":"Price CJ, Wise RJ, Warburton EA, Moore CJ, Howard D, Patterson K et al (1996). Hearing and saying. The functional neuro-anatomy of auditory word processing. Brain 119 (Part 3): 919\u2013931.","journal-title":"Brain"},{"key":"BFnpp201117_CR34","volume-title":"State-Trait Anxiety Inventory For Adults","author":"CG Spielberger","year":"1983","unstructured":"Spielberger CG, Lushene RL, R Vagg PR (1983). State-Trait Anxiety Inventory For Adults. Consulting Psychologists Press: Palo Alto, CA."},{"key":"BFnpp201117_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/archpsyc.1992.01820080032005","volume":"49","author":"RL Spitzer","year":"1992","unstructured":"Spitzer RL, Williams JB, Gibbon M, First MB (1992). The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 49: 624\u2013629.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201117_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/226701a0","volume":"226","author":"CT Tart","year":"1970","unstructured":"Tart CT (1970). Marijuana intoxication common experiences. Nature 226: 701\u2013704.","journal-title":"Nature"},{"key":"BFnpp201117_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0376-8716(96)01277-X","volume":"42","author":"H Thomas","year":"1996","unstructured":"Thomas H (1996). A community survey of adverse effects of cannabis use. Drug Alcohol Depend 42: 201\u2013207.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201117_CR38","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S1053-8119(96)80043-7","volume":"3","author":"SA Williams","year":"1997","unstructured":"Williams SA, Simmons A, Bullmore E, Brammer M (1997). Multiplexed stimuli presentation for functional MRI studies. Neuroimage 3: S41.","journal-title":"Neuroimage"},{"key":"BFnpp201117_CR39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/01688639108401038","volume":"13","author":"D Willshire","year":"1991","unstructured":"Willshire D, Kinsella G, Prior M (1991). Estimating WAIS-R IQ from the National Adult Reading Test: a cross-validation. J Clin Exp Neuropsychol 13: 204\u2013216.","journal-title":"J Clin Exp Neuropsychol"},{"key":"BFnpp201117_CR40","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1176\/ajp.154.12.1676","volume":"154","author":"PW Woodruff","year":"1997","unstructured":"Woodruff PW, Wright IC, Bullmore ET, Brammer M, Howard RJ, Williams SC et al (1997). Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study. Am J Psychiatry 154: 1676\u20131682.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201117_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","volume":"30","author":"AW Zuardi","year":"2008","unstructured":"Zuardi AW (2008). Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr 30: 271\u2013280.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFnpp201117_CR42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1590\/S0100-879X2006000400001","volume":"39","author":"AW Zuardi","year":"2006","unstructured":"Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimar\u00e3es FS (2006). Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 39: 421\u2013429.","journal-title":"Braz J Med Biol Res"}],"updated-by":[{"DOI":"10.1038\/npp.2011.58","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T00:00:00Z","timestamp":1308096000000}}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201117","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:25:04Z","timestamp":1684455904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,16]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["BFnpp201117"],"URL":"https:\/\/doi.org\/10.1038\/npp.2011.17","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/npp.2011.58","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,16]]},"assertion":[{"value":"10 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}